Risk assets push higher on vaccine hopes; eyes on the Fed

6 years ago

By Hussein Sayed, Chief Market Strategist (Gulf & MENA), ForexTime After two consecutive weeks of back-to-back declines, global stocks kicked…

Equities advance as tech stocks rise on acquisition deals

6 years ago

By IFCMarkets.com Top daily news Global markets are rising currently after a bullish session last Friday. Technology shares are leading…

Skyharbour Resources: Athabasca Uranium Story Ready to Run?

6 years ago

Jordan Trimble, CEO of Skyharbour Resources, sits down with Peter Epstein of Epstein Research to discuss the uranium market and…

Look at This Big Reminder of “Dot.com Mania”

6 years ago

Here’s when a surge in IPOs tends to occur - By Elliott Wave International Let's pretend for a second we're…

What Rob McEwen Looks for When Investing in Juniors

6 years ago

Source: Streetwise Reports   09/10/2020 Rob McEwen recaps goings on at McEwen Mining and discusses some of the juniors he has…

Intra-Cellular Shares Soar on Positive Bipolar Depression Study Findings

6 years ago

Source: Streetwise Reports   09/09/2020 Shares of Intra-Cellular Therapies traded 77% higher after the company reported that positive data from its…

As COVID Is Turbocharging the Adoption of TeleHealth, Small Cap Is Growing Exponentially

6 years ago

Source: Streetwise Reports   09/09/2020 All three brokerage firms that cover the rapidly expanding CloudMD Software & Services rate the company…

nCino Shares Rise 11% on Record Q2 Revenues

6 years ago

Source: Streetwise Reports   09/10/2020 Shares of nCino Inc. traded higher after the company reported Q2/21 financial results that included a…

U.S. Medical Device Firm to Acquire Developer of Dissection Stent

6 years ago

Source: Streetwise Reports   09/09/2020 The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg…

Biopharma Achieves ‘Big Phase 3 Win’ for its Pediatric Intrahepatic Cholestasis Drug

6 years ago

Source: Streetwise Reports   09/09/2020 The recent study results of Albireo Pharma's lead therapeutic candidate are discussed in an H.C. Wainwright…

This website uses cookies.